STOCK TITAN
  1. Home
  2. Financials
  3. ITRMF
  4. EPS (Diluted)

ITERUM THERAPEUTICS PLC (ITRMF) EPS by Year

ITRMF

ITERUM THERAPEUTICS PLC lost $1.26 per diluted share in fiscal year 2024. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a loss of $0.71 per diluted share. The table below carries 9 fiscal years, from 2016 to 2024, and the quarters ITERUM THERAPEUTICS PLC has filed alongside them.

FY2024 annual
EPS (Diluted) -$1.26
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ITRMF EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
EPS (Diluted)-$0.71-$1.26-$2.96+18.5%-$3.63-$8.41-$32.49N/AN/AN/AN/A

TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

ITRMF EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-KQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-KQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
EPS (Diluted)-$0.20-$0.16-$0.14-$0.21-$0.30-$0.30+68.4%-$0.46+41.0%-$0.94-129.3%-$0.30+87.4%-$0.95-$0.78-$0.41

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More ITERUM THERAPEUTICS PLC financials

Frequently Asked Questions

What was ITERUM THERAPEUTICS PLC's diluted earnings per share in fiscal year 2024?

ITERUM THERAPEUTICS PLC lost $1.26 per diluted share in fiscal year 2024.

What is ITERUM THERAPEUTICS PLC's diluted earnings per share over the last twelve months?

ITERUM THERAPEUTICS PLC (ITRMF) reported a loss of $0.71 per diluted share over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

What was ITERUM THERAPEUTICS PLC's diluted earnings per share in the most recent quarter?

ITERUM THERAPEUTICS PLC (ITRMF) reported -$0.20 in diluted earnings per share in Q3 2025.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what ITERUM THERAPEUTICS PLC (ITRMF) reported on that line in every period on record.